The 4DMedical Ltd (ASX: 4DX) share price is surging today, up 39.6% after posting gains of as much as 95% in early morning trade.
4DMedical shares closed yesterday at 36 cents and are currently trading for 51 cents.
So whatâs driving ASX investor interest in the respiratory imaging technology company?
Nationwide contract inked
The 4DMedical share price is rocketing after the company reported it has signed a nationwide contract with I-MED Radiology Network. I-MED has more than 250 clinics across Australia.
The new three-year agreement formalises an existing commercial arrangement between the two companies. 4DMedical is now cleared to send its lung imaging technology to other selected clinics across I-MEDâs network.
Atop the agreement, the company said its agreed to establish a Lung Centre of Excellence together with I-MED. Employing its ling imaging technology, 4DMedical said the centre will “enable world-class research and development activities to advance diagnostic imaging throughout Australia”.
The 4DMedical share price could also be getting a lift from the companyâs report that the collaboration with I-MED could streamline the adoption processes of its diagnostic imaging technology without requiring extensive pilot programs.
Commenting on the development
4DMedical CEO, Andreas Fouras said:
Expansion of our proven capability nationwide means many more people will be able to access the latest technology in respiratory imaging. Beyond putting our innovative technology in the reach of more people, this deal represents a significant opportunity to drive revenue for the company. Additionally, this agreement creates a framework for the rapid commercialisation of future 4DMedical products.
I-MED CEO Shrey Viranna added, “Activating this arrangement augments I-MEDâs world-class diagnostic imaging offering through access to 4DMedicalâs unique functional lung imaging technology.”
4DMedical share price snapshot
Despite todayâs big lift, the 4DMedical share price remains down 59% in 2022. By comparison, the All Ordinaries Index (ASX: XAO) is down 13% year-to-date.
The post Why is the 4DMedical share price exploding 40% today? appeared first on The Motley Fool Australia.
Should you invest $1,000 in 4dmedical Limited right now?
Before you consider 4dmedical Limited, you’ll want to hear this.
Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and 4dmedical Limited wasn’t one of them.
The online investing service heâs run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.
See The 5 Stocks
*Returns as of June 1 2022
(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}
setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()
More reading
- Why is the BlueBet share price rocketing 16% today?
- Why is the PointsBet share price sinking on Tuesday?
- Do Adairs shares really boast a 9% dividend yield?
- ASX 200 midday update: Tech shares tumble, Collins Foods jumps
- Why this smaller ASX travel share is locking horns with Qantas over regulation
Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
from The Motley Fool Australia https://ift.tt/GZpEs4U
Leave a Reply